Prediction of VLCAD deficiency phenotype by a metabolic fingerprint in newborn screening bloodspots
Open Access
- 1 June 2020
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1866 (6) , 165725
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- The Biochemistry and Physiology of Mitochondrial Fatty Acid β-Oxidation and Its Genetic DisordersAnnual Review of Physiology, 2016
- Fatty acid oxidation flux predicts the clinical severity of VLCAD deficiencyGenetics in Medicine, 2015
- Mass spectrometry‐based metabolomics: applications to biomarker and metabolic pathway researchBiomedical Chromatography, 2015
- Metabonomics of Newborn Screening Dried Blood Spot Samples: A Novel Approach in the Screening and Diagnostics of Inborn Errors of MetabolismAnalytical Chemistry, 2012
- MetPA: a web-based metabolomics tool for pathway analysis and visualizationBioinformatics, 2010
- The enzymology of mitochondrial fatty acid beta‐oxidation and its application to follow‐up analysis of positive neonatal screening resultsJournal of Inherited Metabolic Disease, 2010
- Newborn screening for disorders of fatty‐acid oxidation: experience and recommendations from an expert meetingJournal of Inherited Metabolic Disease, 2010
- Mitochondrial long chain fatty acid β-oxidation in man and mouseBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2009
- MS/MS-based newborn and family screening detects asymptomatic patients with very-long-chain acyl-CoA dehydrogenase deficiencyThe Journal of Pediatrics, 2003
- Clear Correlation of Genotype with Disease Phenotype in Very–Long-Chain Acyl-CoA Dehydrogenase DeficiencyThe American Journal of Human Genetics, 1999